Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both Maria Waldhoer on the web LinkedIn T witter Pubmed Dr. GPCR About Dr. JoAnn Trejo "Dr. GPCR About Anne Marie Quinn "Anne Marie Quinn has a long and varied work experience in the biocomputing Anne Marie Quinn attended Yale University from 1998 to 2000, where they earned a Master of Public Health Anne Marie Quinn on the web Google Scholar The Org LinkedIn Twitter Dr. GPCR Unlock the Full Dr.

." - Anne Marie Quinn, CEO Montana Molecular Frequently Asked Questions 01 What kinds of CROs do you

Anne Marie Quinn, CEO Montana Molecular As a CRO, we were delivering high-quality data across complex Bringing her in marked a meaningful shift.

Founder & Director Yamina Berchiche Get in touch Co-Founder Attila Foris Get in touch Board Member Anne Quinn Get in touch Board Member JoAnn Trejo Get in touch Board Member Maria Waldhoer Get in touch Chief Matchmaker Mark Schmeizl Get in touch

Your Journey Today Meet the Leadership Founder & Director Yamina Berchiche Get in Touch Board Member Anne Quinn Get in Touch Board Member Maria Waldhoer Get in Touch Co-Founder Attila Foris Get in Touch Board Member JoAnn Trejo Get in Touch Chief Matchmaker Mark Schmeizl Get in Touch Why Upgrade to Premium Everyone

I was recently awarded a Marie Sklodowska Curie PostDoc Fellowship in order to investigate and find better

Andrew Tobin Andrew Tobin studied Biochemistry at Queen Mary College, the University of London obtaining

After doctoral training at the Pierre and Marie Curie University in Paris and a short internship at Genentech the CNRS as a Research Fellow in 1987 in the INSERM Laboratory directed by Jean-Charles Schwartz in Paris From 91 to 94, he was an assistant professor at Duke University in North Carolina, working with Marc Neurobiology of Psychiatric Disorders," first in Créteil with Marion Leboyer, then at the University of Paris-Sorbonne

Streicher on how HSP90 flips direction between brain and spinal cord, why isoform-selective inhibitors may plays directly opposite roles in the brain and the spinal cord, why isoform-selective HSP90 inhibitors may Mary Canals' group has argued that some of the apparent bias benefits may actually reflect low intrinsic

. << Back to podcast list Strategic Partner(s) Kari Johnson: mGlu2, Addiction, and the Brain Circuits Kari Johnson's research follows this receptor from the bench to the behaving animal, using optogenetics ABOUT THE GUEST Kari Johnson is an assistant professor of neuropharmacology at the Uniformed Services It is also a complication: a receptor that modulates so many circuits will inevitably produce wanted Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.

She began her Ph.D. at Imperial College London with Prof Aylin Hanyaloglu, Prof Gary Frost, and Dr.

California at Irvine, studying the regulation of ionotropic glutamate receptors under the direction of Gary

Joining the conversation are Maria Majellaro (CSO and co-founder of Celtarys Research), Johannes Broichhagen Broichhagen About the Guests Maria Majellaro, PhD Dr. Maria Majellaro is the Chief Scientific Officer and co-founder of Celtarys Research , a biotech spin-off She earned her PhD in medicinal chemistry from the University of Bari in 2018, including research training Guests on The Web Maria Majellaro LinkedIn ResearchGate Ecosystem Johannes Broichhagen LinkedIn Google

Maria Majellaro Co-Funder and CSO Dr. Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari validation strategy, and performance across reference antagonists and agonis Lucía from Celtarys Research Mar Maria Majellaro, CSO of Celtarys. “Working with Dr.

Maria Majellaro—and learn what their new partnership with Dr. “We started with GPCRs, but now we’re expanding to many new targets. Translating Science into Business Like many scientists-turned-entrepreneurs, Maria faced the challenge About Maria Majellaro Dr. at the University of Bari (Italy) in 2018.